Market
BSE Prices delayed by 5 minutes... << Prices as on Oct 16, 2026 - 3:59PM >>  ABB India  6816 [ -0.13% ] ACC  1193.4 [ 4.88% ] Ambuja Cements  362.9 [ 3.98% ] Asian Paints  2333 [ -1.00% ] Axis Bank  1286.45 [ -0.16% ] Bajaj Auto  10417 [ 0.52% ] Bank of Baroda  230 [ 0.83% ] Bharti Airtel  1905 [ 2.86% ] Bharat Heavy  434.1 [ -0.14% ] Bharat Petroleum  294 [ 0.15% ] Britannia Industries  4780 [ -2.32% ] Cipla  1325 [ -0.65% ] Coal India  416.9 [ -0.50% ] Colgate Palm  1772.55 [ -0.53% ] Dabur India  386 [ 0.26% ] DLF  674 [ 0.66% ] Dr. Reddy's Lab.  1231.85 [ 0.91% ] GAIL (India)  168.25 [ -0.27% ] Grasim Industries  2921 [ 0.62% ] HCL Technologies  1378 [ 1.08% ] HDFC Bank  728.1 [ -0.06% ] Hero MotoCorp  5230 [ 0.57% ] Hindustan Unilever  1898 [ 0.20% ] Hindalco Industries  910 [ 1.79% ] ICICI Bank  1396.8 [ 0.13% ] Indian Hotels Co.  772 [ 4.32% ] IndusInd Bank  874 [ -1.24% ] Infosys  1161.6 [ 4.55% ] ITC  263 [ -0.66% ] Jindal Steel  1040.4 [ 1.01% ] Kotak Mahindra Bank  446 [ -0.63% ] L&T  3632 [ -0.66% ] Lupin  1955.8 [ -0.17% ] Mahi. & Mahi  2920 [ 2.38% ] Maruti Suzuki India  11482 [ 0.50% ] MTNL  23.53 [ -0.34% ] Nestle India  1265 [ -1.17% ] NIIT  85.81 [ -1.55% ] NMDC  71.7 [ 1.10% ] NTPC  316.5 [ 0.76% ] ONGC  222.2 [ -1.20% ] Punj. NationlBak  116.1 [ 0.78% ] Power Grid Corpn.  250.95 [ 0.38% ] Reliance Industries  1210 [ -1.09% ] SBI  961.7 [ 0.02% ] Vedanta  246.5 [ 0.16% ] Shipping Corpn.  284.85 [ 0.26% ] Sun Pharmaceutical  1760 [ -0.03% ] Tata Chemicals  632.4 [ 0.72% ] Tata Consumer  977.2 [ -1.70% ] Tata Motors Passenge  286.9 [ 0.02% ] Tata Steel  175.6 [ -0.48% ] Tata Power Co.  353.45 [ 1.19% ] Tata Consult. Serv.  2463 [ 4.61% ] Tech Mahindra  1788 [ 8.45% ] UltraTech Cement  10928 [ 0.58% ] United Spirits  1376.1 [ -0.71% ] Wipro  184.4 [ 6.16% ] Zee Entertainment  72.01 [ -1.02% ] 
Jagsonpal Pharmaceuticals Ltd. Auditor Report
Search Company 
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 1440.31 Cr. P/BV 4.98 Book Value (Rs.) 43.84
52 Week High/Low (Rs.) 265/155 FV/ML 2/1 P/E(X) 33.43
Bookclosure 04/09/2026 EPS (Rs.) 6.53 Div Yield (%) 1.83
Year End :2026-03 

1. We have audited the accompanying financial statements
of Jagsonpal Pharmaceuticals Limited ('the Company'),
which comprise the Balance Sheet as at 31 March 2026,
the Statement of Profit and Loss (including Other
Comprehensive Income), the Statement of Cash Flow
and the Statement of Changes in Equity for the year
then ended, and notes to the financial statements,
including material accounting policy information and
other explanatory information.

2. In our opinion and to the best of our information and
according to the explanations given to us, the aforesaid
financial statements give the information required by
the Companies Act, 2013 ('the Act') in the manner so
required and give a true and fair view in conformity with
the Indian Accounting Standards ('Ind AS') specified
under section 133 of the Act read with the Companies
(Indian Accounting Standards) Rules, 2015 and other
accounting principles generally accepted in India, of the
state of affairs of the Company as at 31 March 2026, and
its profit (including other comprehensive income), its
cash flows and the changes in equity for the year ended
on that date.

Basis for Opinion

3. We conducted our audit in accordance with the
Standards on Auditing specified under section 143(10)
of the Act. Our responsibilities under those standards
are further described in the Auditor's Responsibilities
for the Audit of the Financial Statements section of
our report. We are independent of the Company in
accordance with the Code of Ethics issued by the Institute
of Chartered Accountants of India ('ICAI') together with
the ethical requirements that are relevant to our audit
of the financial statements under the provisions of the
Act and the rules thereunder, and we have fulfilled our
other ethical responsibilities in accordance with these
requirements and the Code of Ethics. We believe that
the audit evidence we have obtained is sufficient and
appropriate to provide a basis for our opinion.

Key Audit Matter

4. Key audit matters are those matters that, in our
professional Judgment, were of most significance in
our audit of the financial statements of the current
period. These matters were addressed in the context
of our audit of the financial statements as a whole, and
in forming our opinion thereon, and we do not provide
a separate opinion on these matters.

5. We have determined the matter described below to be
the key audit matter to be communicated in our report.

Key audit matters

How our audit addressed the key audit matters

Revenue from sale of products:

Refer notes 2(d)(vii) and 21 to the financial statements
for material accounting policy information and revenue
related disclosures respectively.

The Company recognises revenue from the sale of
pharmaceutical products when control of such products
is transferred to the customer and there are no longer any
unfulfilled obligations. Revenue towards a performance
obligation is measured at the amount of transaction
price allocated to that performance obligation and is
accounted for net of rebates or discounts.

The Company has a large number of customers
operating in various geographies throughout the
country and the sales contracts/arrangements with
such customers have distinct/varying commercial
terms. Accordingly, Ind AS 115, Revenue from Contracts
with Customers ('Ind AS 115') requires management to
make certain Judgement/estimates such as determining
timing of transfer of control for revenue recognition and
determining transaction price as per the terms of the
contracts and arrangements.

Our audit procedures in relation to revenue from sale of products
included, but were not limited to the following:

- Obtained understanding of the revenue business
processes of the Company;

- Assessed the appropriateness of revenue recognition
policy of the Company in accordance with Ind AS 115;

- Involved our IT specialists to evaluate the design and test
operating effectiveness of IT general controls and key
automated controls of the Company's IT system which
is used for revenue recognition;

- Evaluated the design and tested the operating
effectiveness of key manual controls over revenue
recognition;

- Performed substantive analytical procedures which
includes margin analysis and period-on-period variance
analysis on revenue recognised during the year to
identify any unusual indicators/trends;

- Performed test of details by selecting samples of revenue
transactions pertaining to sale of products recorded
during the year and verified the underlying supporting
documents including contracts / agreements, sales
invoices, proofs of dispatch and delivery etc.;

Key audit matters

How our audit addressed the key audit matters

Further, the Company considers revenue as a key
benchmark for evaluating performances and hence,
there is risk of revenue being overstated due to
pressure to achieve targets and earning expectations
and therefore, in line with the requirements of the
Standards on Auditing, revenue is determined to be an
area involving significant risk which requires significant
auditor attention.

Owing to the amounts involved, volume of sales
transactions, distinct/varied terms of contracts with
customers and above-mentioned judgement/estimate,
revenue from sale of products has been considered as
a key audit matter for current year audit.

- Performed testing by selecting samples pertaining to
revenue transactions recorded during specific period
before the year end and after the year end to ensure
revenue from such transactions is recorded in the correct
period;

- Obtained management workings for amounts recognised
towards rebates/discounts and returns during the
year and as at year end. On a sample basis, tested the
underlying calculations for amounts recorded as accruals
and provisions (if any) towards the aforementioned
obligations, as per the terms of related contracts and
regulations, and traced the underlying data to source
documents; and

- Evaluated the appropriateness and adequacy of the
related presentation and disclosures made in the
financial statements in accordance with the requirements
of applicable accounting standards.


Information other than the Financial Statements
and Auditor's Report thereon

6. The Company's Board of Directors are responsible
for the other information. The other information
comprises the information included in the Annual
Report but does not include the financial statements
and our auditor's report thereon. The Annual Report is
expected to be made available to us after the date of
this auditor's report.

Our opinion on the financial statements does not cover
the other information and we do not express any form
of assurance conclusion thereon.

In connection with our audit of the financial statements,
our responsibility is to read the other information and,
in doing so, consider whether the other information is
materially inconsistent with the financial statements
or our knowledge obtained in the audit or otherwise
appears to be materially misstated.

When we read the Annual Report, if we conclude
that there is a material misstatement therein, we are
required to communicate the matter to those charged
with governance.

Responsibilities of Management and Those Charged
with Governance for the Financial Statements

7. The accompanying financial statements have been
approved by the Company's Board of Directors. The
Company's Board of Directors are responsible for
the matters stated in section 134(5) of the Act with
respect to the preparation and presentation of these
financial statements that give a true and fair view of
the financial position, financial performance including
other comprehensive income, changes in equity and
cash flows of the Company in accordance with the
Ind AS specified under section 133 of the Act and
other accounting principles generally accepted in
India. This responsibility also includes maintenance of
adequate accounting records in accordance with the
provisions of the Act for safeguarding of the assets of

the Company and for preventing and detecting frauds
and other irregularities; selection and application of
appropriate accounting policies; making Judgments and
estimates that are reasonable and prudent; and design,
implementation and maintenance of adequate internal
financial controls, that were operating effectively
for ensuring the accuracy and completeness of the
accounting records, relevant to the preparation and
presentation of the financial statements that give a true
and fair view and are free from material misstatement,
whether due to fraud or error.

8. In preparing the financial statements, the Board of
Directors is responsible for assessing the Company's
ability to continue as a going concern, disclosing, as
applicable, matters related to going concern and using
the going concern basis of accounting unless the Board
of Directors either intends to liquidate the Company or
to cease operations, or has no realistic alternative but
to do so.

9. The Board of Directors is also responsible for overseeing
the Company's financial reporting process.

Auditor's Responsibilities for the Audit of the
Financial Statements

10. Our objectives are to obtain reasonable assurance
about whether the financial statements as a whole
are free from material misstatement, whether due
to fraud or error, and to issue an auditor's report
that includes our opinion. Reasonable assurance is a
high level of assurance, but is not a guarantee that
an audit conducted in accordance with Standards on
Auditing will always detect a material misstatement
when it exists. Misstatements can arise from fraud or
error and are considered material if, individually or in
the aggregate, they could reasonably be expected to
influence the economic decisions of users taken on the
basis of these financial statements.

11. As part of an audit in accordance with Standards on
Auditing, specified under section 143(10) of the Act,

we exercise professional judgment and maintain
professional skepticism throughout the audit. We also:

• Identify and assess the risks of material
misstatement of the financial statements,
whether due to fraud or error, design and
perform audit procedures responsive to
those risks, and obtain audit evidence that is
sufficient and appropriate to provide a basis
for our opinion. The risk of not detecting a
material misstatement resulting from fraud
is higher than for one resulting from error, as
fraud may involve collusion, forgery, intentional
omissions, misrepresentations, or the override of
internal control;

• Obtain an understanding of internal control
relevant to the audit in order to design
audit procedures that are appropriate in the
circumstances. Under section 143(3)(i) of the
Act, we are also responsible for expressing our
opinion on whether the Company has adequate
internal financial controls with reference to
financial statements in place and the operating
effectiveness of such controls;

• Evaluate the appropriateness of accounting
policies used and the reasonableness of
accounting estimates and related disclosures
made by management;

• Conclude on the appropriateness of Board of
Directors' use of the going concern basis of
accounting and, based on the audit evidence
obtained, whether a material uncertainty exists
related to events or conditions that may cast
significant doubt on the Company's ability to
continue as a going concern. If we conclude that
a material uncertainty exists, we are required

to draw attention in our auditor's report to the
related disclosures in the financial statements or,
if such disclosures are inadequate, to modify our
opinion. Our conclusions are based on the audit
evidence obtained up to the date of our auditor's
report. However, future events or conditions may
cause the Company to cease to continue as a
going concern; and

• Evaluate the overall presentation, structure and
content of the financial statements, including the
disclosures, and whether the financial statements
represent the underlying transactions and events
in a manner that achieves fair presentation.

12. We communicate with those charged with governance
regarding, among other matters, the planned scope
and timing of the audit and significant audit findings,
including any significant deficiencies in internal control
that we identify during our audit.

13. We also provide those charged with governance with
a statement that we have complied with relevant

ethical requirements regarding independence, and
to communicate with them all relationships and
other matters that may reasonably be thought to
bear on our independence, and where applicable,
related safeguards.

14. From the matters communicated with those charged
with governance, we determine those matters that
were of most significance in the audit of the financial
statements of the current period and are therefore,
the key audit matters. We describe these matters in
our auditor's report unless law or regulation precludes
public disclosure about the matter or when, in extremely
rare circumstances, we determine that a matter should
not be communicated in our report because the
adverse consequences of doing so would reasonably
be expected to outweigh the public interest benefits
of such communication.

Report on Other Legal and Regulatory
Requirements

15. As required by section 197(16) of the Act, based
on our audit, we report that the Company has paid
remuneration to its directors during the year in
accordance with the provisions of and limits laid down
under section 197 read with Schedule V to the Act.

16. As required by the Companies (Auditor's Report) Order,
2020 ('the Order') issued by the Central Government
of India in terms of section 143(11) of the Act, we
give in the Annexure I a statement on the matters
specified in paragraphs 3 and 4 of the Order, to the
extent applicable.

17. Further to our comments in Annexure I, as required by
section 143(3) of the Act, based on our audit, we report,
to the extent applicable, that:

a) We have sought and obtained all the information
and explanations which to the best of our
knowledge and belief were necessary for the
purpose of our audit of the accompanying
financial statements;

b) Except for the matters stated in paragraph 17(h)
(vi) below on reporting under Rule 11(g) of the
Companies (Audit and Auditors) Rules, 2014
(as amended), in our opinion, proper books of
account as required by law have been kept by the
Company so far as it appears from our examination
of those books;

c) The financial statements dealt with by this report
are in agreement with the books of account;

d) In our opinion, the aforesaid financial statements
comply with Ind AS specified under section 133 of
the Act;

e) On the basis of the written representations
received from the directors and taken on record
by the Board of Directors, none of the directors
is disqualified as on 31 March 2026 from being
appointed as a director in terms of section 164(2)
of the Act;

f) The modification relating to the maintenance of
accounts and other matters connected therewith
are as stated in paragraph 17 b) above on reporting
under section 143(3)(b) of the Act and paragraph
17(h)(vi) below on reporting under Rule 11(g) of
the Companies (Audit and Auditors) Rules, 2014
(as amended);

g) With respect to the adequacy of the internal
financial controls with reference to financial
statements of the Company as on 31 March 2026
and the operating effectiveness of such controls,
refer to our separate report in Annexure II wherein
we have expressed an unmodified opinion; and

h) With respect to the other matters to be included
in the Auditor's Report in accordance with rule 11
of the Companies (Audit and Auditors) Rules, 2014
(as amended), in our opinion and to the best of
our information and according to the explanations
given to us:

i. the Company, as detailed in note 38 to the
financial statements, has disclosed the impact
of pending litigations on its financial position
as at 31 March 2026;

ii. the Company did not have any long-term
contracts including derivative contracts for
which there were any material foreseeable
losses as at 31 March 2026;

iii. there were no amounts which were required
to be transferred to the Investor Education
and Protection Fund by the Company during
the year ended 31 March 2026;

iv. (a) The management has represented that,

to the best of its knowledge and belief,
disclosed in note 45(i) to the financial
statements, no funds have been
advanced or loaned or invested (either
from borrowed funds or securities
premium or any other sources or kind
of funds) by the Company to or in any
person(s) or entity(ies), including foreign
entities ('the intermediaries'), with
the understanding, whether recorded
in writing or otherwise, that the
intermediary shall, whether, directly or
indirectly lend or invest in other persons
or entities identified in any manner
whatsoever by or on behalf of the
Company ('the Ultimate Beneficiaries')
or provide any guarantee, security or the
like on behalf the Ultimate Beneficiaries;

b) The management has represented
that, to the best of its knowledge and
belief, as disclosed in note 45 (ii) to the
financial statements, no funds have
been received by the Company from any
person(s) or entity(ies), including foreign
entities ('the Funding Parties'), with the
understanding, whether recorded in
writing or otherwise, that the Company
shall, whether directly or indirectly, lend
or invest in other persons or entities
identified in any manner whatsoever
by or on behalf of the Funding Party
('Ultimate Beneficiaries') or provide any
guarantee, security or the like on behalf
of the Ultimate Beneficiaries; and

(c) Based on such audit procedures
performed as considered reasonable
and appropriate in the circumstances,
nothing has come to our notice that
has caused us to believe that the
management representations under
sub-clauses (a) and (b) above contain
any material misstatement.

v. The final dividend paid by the Company during
the year ended 31 March 2026 in respect
of such dividend declared for the previous
year is in accordance with section 123 of
the Act to the extent it applies to payment
of dividend. Further, as stated in note 35(b)
to the accompanying financial statements,
the Board of Directors of the Company have
proposed final dividend for the year ended 31
March 2026 which is subject to the approval
of the members at the ensuing Annual
General Meeting. The dividend declared is in
accordance with section 123 of the Act to the
extent it applies to declaration of dividend.

vi. As stated in note 46 to the financial
statements and based on our examination
which included test checks, the Company, in
respect of financial year commencing on 1
April 2025, has used an accounting software
for maintaining its books of account and a
software for maintaining its employee related
records with effect from 01 September 2025,
which is operated by a third-party software
service provider. Such software have a feature
of recording audit trail (edit log) facility and
the same has been operated throughout the
year for all relevant transactions recorded
in the softwares except for the exceptions
given below. Further, during the course of our

audit we did not come across any instance
of audit trail feature being tampered with,
other than the consequential impact of
the exceptions given below. Furthermore,
other than the consequential impact of the
exceptions given below, the audit trail has
been preserved by the Company as per the
statutory requirements for record retention.

• The audit trail feature at database
level in the accounting software used
for maintaining books of account was
enabled for all users with effect from
01 January 2026 to log any direct data
changes; and

• Another accounting software used
for maintenance of employee related
records is operated by a third-
party software service provider.

In the absence of any evidence
in 'Independent Service Auditor's

Assurance Report on the Description of
Controls, their Design and Operating
Effectiveness' ('Type 2 report' issued in
accordance with SAE 3402, Assurance
Reports on Controls at a Service
Organization), we are unable to
comment on whether the audit trail
has been preserved by the Company
as per the statutory requirements for
record retention.

For Walker Chandiok & Co LLP

Chartered Accountants
Firm's Registration No.: 001076N/N500013

Madhu Sudan Malpani

Partner

Membership No.: 517440
UDIN: 26517440ICAGQZ9298

Place: Gurugram
Date: 27 April 2026


 
KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Stocks A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Others
MUTUAL FUND A B C D E F G H I J K L M N O P Q R S T U V W X Y Z OTHERS
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | MCX | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting | SMART ODR | ODR CIRCULAR
 
Charts are powered by TradingView.
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by